4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001104659-15-081132
Director acquired 564,948 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coleman Mark Director | 2015-11-24 | Conversion | +243,750 | $5.40 | $1,316,250 | 326,800 | D |
| Coleman Mark Director | 2015-11-24 | Conversion | +180,526 | $5.94 | $1,072,324 | 507,326 | D |
| Coleman Mark Director | 2015-11-24 | Conversion | +140,672 | $5.94 | $835,592 | 647,998 | D |
| Derivatives | |||||||
| Coleman Mark Director | 2015-11-24 | Grant or award · 8% Convertible Note | +243,750 | 0 | D | ||
| Coleman Mark Director | 2015-11-24 | Grant or award · 8% Convertible Note | +180,526 | 0 | D | ||
| Coleman Mark Director | 2015-11-24 | Grant or award · 8% Convertible Note | +140,672 | 0 | D | ||
Loading xslF345X03/a4.xml…